Evaluation of cross-platform compatibility of a DNA methylation-based glucocorticoid response biomarker

Overview of attention for article published in Clinical Epigenetics, October 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (73rd percentile)

So far, Altmetric has seen 7 X posts from 5 X users, with an upper bound of 22,693 followers.

RT @NeurosurgUCSF: In a recent study led by @AnnetteMolinar2, researchers developed a DNA methylation #biomarker that characterizes a patie…

RT @NeurosurgUCSF: In a recent study led by @AnnetteMolinar2, researchers developed a DNA methylation #biomarker that characterizes a patie…

RT @lsalas_epigenet: New manuscript alert. https://t.co/wOiztGAC8r. New algorithm reproducing the DNA methylation glucocorticoid response s…

RT @NeurosurgUCSF: In a recent study led by @AnnetteMolinar2, researchers developed a DNA methylation #biomarker that characterizes a patie…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.